OPEN END TURBO PUT WARRANT - PFIZER INC | Market Closed - Boerse Frankfurt Warrants 01:35:47 2024-07-11 pm EDT | ||
| 3.79 EUR | -1.04% |
|
| Current month | -3.07% | ||
| 1 month | -2.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 3.79 | -1.04% |
| 24-07-10 | 3.83 | -1.79% |
| 24-07-09 | 3.9 | +0.78% |
| 24-07-08 | 3.87 | +0.26% |
| 24-07-05 | 3.86 | -0.26% |
Real-time Boerse Frankfurt Warrants
Last update July 11, 2024 at 01:35 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UH5CGV |
| ISIN | DE000UH5CGV4 |
| Date issued | 2021-12-03 |
| Strike | 69.57 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.21 € |
|---|---|
| Lowest since issue | 1.34 € |
| Spread | 0.01 € |
| Spread % | 0.26% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Certificates
- Certificat
